TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 34 filers reported holding TOKAI PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $343,000 | +4.9% | 409,813 | +22.6% | 0.00% | – |
| Q4 2016 | $327,000 | +91.2% | 334,363 | +200.0% | 0.00% | – |
| Q3 2016 | $171,000 | -87.9% | 111,454 | -56.6% | 0.00% | – |
| Q2 2016 | $1,414,000 | +1.1% | 256,582 | +2.8% | 0.00% | – |
| Q1 2016 | $1,399,000 | -33.3% | 249,485 | +3.8% | 0.00% | – |
| Q4 2015 | $2,097,000 | -11.9% | 240,466 | +4.6% | 0.00% | – |
| Q3 2015 | $2,380,000 | -11.3% | 229,956 | +14.0% | 0.00% | – |
| Q2 2015 | $2,683,000 | +23.9% | 201,712 | +5.2% | 0.00% | – |
| Q1 2015 | $2,166,000 | -7.2% | 191,673 | +21.0% | 0.00% | – |
| Q4 2014 | $2,334,000 | – | 158,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 637,110 | $3,574,187,000 | 0.71% |
| Novo Holdings A/S | 470,946 | $2,642,000 | 0.29% |
| Perceptive Advisors | 485,338 | $2,723,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 812,200 | $4,556,000 | 0.23% |
| FNY Managed Accounts LLC | 6,438 | $36,117,000 | 0.06% |
| NJ State Employees Deferred Compensation Plan | 35,000 | $271,000 | 0.06% |
| Alyeska Investment Group, L.P. | 315,757 | $1,771,000 | 0.02% |
| ROPES WEALTH ADVISORS LLC | 6,000 | $34,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $337,000 | 0.01% |
| BlackRock Fund Advisors | 530,538 | $2,976,000 | 0.00% |